European Journal of Surgical Oncology
Volume 35, Issue 12 , Pages 1299-1305 , December 2009

Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection

,Accepted 2 July 2009.

References 

  1. Saunders M, Iveson T. Management of advanced colorectal cancer: state of the art. British Journal of Cancer. 2006 Jul 17;95(2):131–138
  2. Giacchetti S, Perpoint B, Zidani R, et al. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil–leucovorin as first-line treatment of metastatic colorectal cancer. Journal of Clinical Oncology. 2000 Jan;18(1):136–147
  3. Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. New England Journal of Medicine. 2000;343(13):905–914
  4. Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Annals of Thoracic Surgery. 2007 Jul;84(1):324–338
  5. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. British Journal of Cancer. 2006 Apr 10;94(7):982–999
  6. Yan TD, Black D, Savady R, Sugarbaker PH. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. Journal of Clinical Oncology. 2006 Aug 20;24(24):4011–4019
  7. Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. Journal of Clinical Oncology. 2003;21(20):3737–3743
  8. Yan TD, Sim J, Morris DL. Selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and perioperative intraperitoneal chemotherapy. Annals of Surgical Oncology. 2007 Jun;14(6):1807–1817
  9. Kemeny N, Fata F. Arterial, portal or systemic chemotherapy for patients with hepatic metastasis of colorectal carcinoma. Journal of Hepatobiliary Pancreatic Surgery. 1999;6:39–49
  10. Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumours of the liver. Cancer. 1969;23:198–202
  11. Yan TD, Morris DL. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care?. Annals of Surgery. 2008;248(5):829–835
  12. Jacquet P, Sugarbaker PH. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. Journal of Experimental and Clinical Cancer Research. 1996;15:49–58
  13. Sugarbaker PH. Peritonectomy procedures. Annals of Surgery. 1995 Jan;221(1):29–42
  14. Verwaal VJ, Kusamura S, Baratti D, Deraco M. The eligibility for local–regional treatment of peritoneal surface malignancy. Journal of Surgical Oncology. 2008 Sep 15;98(4):220–223
  15. Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. British Journal of Surgery. 2002;89(12):1545–1550
  16. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. New England Journal of Medicine. 2004;350(23):2335–2342
  17. Kianmanesh R, Scaringi S, Sabate J-M, et al. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Annals of Surgery. 2007 Apr;245(4):597–603
  18. Elias D, Benizri E, Pocard M, Ducreux M, Boige V, Lasser P. Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer. European Journal of Surgical Oncology. 2006 Aug;32(6):632–636
  19. Viadana E, Bross ID, Pickren JW. The metastatic spread of cancers of the digestive system in man. Oncology. 1978;35:114–126
  20. McMahon G. VEGF receptor signaling in tumor angiogenesis. The Oncologist. 2000;5:s3–s10
  21. Russell AH, Pelton J, Reheis CE, Wisbeck WM, Tony DY, Dawson LE. Adenocarcinoma of the colon: an autopsy study with implications for new therapeutic strategies. Cancer. 1985;56:1446–1451
  22. Carmignani CP, Sugarbaker TA, Bromley CM, Sugarbaker PH. Intraperitoneal cancer dissemination: mechanisms of the patterns of spread. Cancer & Metastasis Reviews. 2003 Dec;22(4):465–472
  23. Goldberg RM, Rothenberg ML, Van Cutsem E, et al. The continuum of care: a paradigm for the management of metastatic colorectal cancer. Oncologist. 2007 Jan;12(1):38–50
  24. Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist. 2008 Jan;13(1):51–64

PII: S0748-7983(09)00227-3

doi: 10.1016/j.ejso.2009.07.005

European Journal of Surgical Oncology
Volume 35, Issue 12 , Pages 1299-1305 , December 2009

Article Tools

* Image Usage & Resolution